Vivani Medical Stock (NASDAQ:VANI)

Ownership Financials Chart

Previous Close

$1.39

52W Range

$0.92 - $1.92

50D Avg

$1.26

200D Avg

$1.31

Market Cap

$110.38M

Avg Vol (3M)

$474.54K

Beta

3.29

Div Yield

VANI Company Profile

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-27.56M	$-24.68M	$-26.96M
Net Income	$-26.61M	$-23.49M	$-25.65M
EBITDA	$-27.56M	$-24.28M	$-25.30M
Basic EPS	$-0.43	$-0.43	$-0.50
Diluted EPS	$-0.43	$-0.43	$-0.50

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 4:30 PM

Q3 19Nov 14, 19 | 4:30 PM

Q2 19Aug 06, 19 | 4:30 PM

Peer Comparison

Ticker	Company
IMA	ImageneBio Inc
MBOT	Microbot Medical Inc.
QIPT	Quipt Home Medical Corp.
CRDL	Cardiol Therapeutics Inc.
NSPR	InspireMD, Inc.
ORMP	Oramed Pharmaceuticals Inc.
RCEL	Avita Medical Inc.
FONR	FONAR Corporation
HYPR	Hyperfine, Inc.